Colorectal clinical trials

Explore recruiting colorectal clinical trials.

Recruiting colorectal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2a exploratory study of TAR-0520 gel in prevention of Hand and Foot Syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

​​A Phase II, Open-Label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants with Colorectal Cancer (CANTOR)

Spain, France, Netherlands, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 2a multicentric study of TAR-0520 gel in EGFR inhibitor-induced folliculitis

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Circulating tumour DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE) AIO-KRK-0217.

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with positive ctDNA after surgery and adjuvant chemotherapy for a high-risk stage II and stage III Colorectal Cancer

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mesalamine for colorectal cancer prevention program in Lynch syndrome

Sweden, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Colorectal trials by city

Colorectal in Toronto Colorectal in Vancouver Colorectal in Montreal Colorectal in Calgary Colorectal in Edmonton Colorectal in Ottawa Colorectal in Winnipeg Colorectal in Quebec City Colorectal in Hamilton Colorectal in Kitchener Colorectal in London Colorectal in Halifax Colorectal in New York Colorectal in Los Angeles Colorectal in Chicago Colorectal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease